Accessibility Menu
 
Alector logo

Alector

(NASDAQ) ALEC

Current Price$2.01
Market Cap$220.73M
Since IPO (2019)-89%
5 Year-88%
1 Year+50%
1 Month-16%

Alector Financials at a Glance

Market Cap

$220.73M

Revenue (TTM)

$21.05M

Net Income (TTM)

$142.93M

EPS (TTM)

$-1.39

P/E Ratio

-1.44

Dividend

$0.00

Beta (Volatility)

1.66 (High)

Price

$2.01

Volume

16,517

Open

$2.13

Previous Close

$2.01

Daily Range

$1.99 - $2.13

52-Week Range

$0.87 - $3.40

ALEC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alector

Industry

Biotechnology

Employees

103

CEO

Arnon Rosenthal, PhD

Headquarters

South San Francisco, CA 94080, US

ALEC Financials

Key Financial Metrics (TTM)

Gross Margin

89%

Operating Margin

-7%

Net Income Margin

-7%

Return on Equity

-182%

Return on Capital

-65%

Return on Assets

-49%

Earnings Yield

-69.44%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$220.73M

Shares Outstanding

110.36M

Volume

16.52K

Short Interest

0.00%

Avg. Volume

908.48K

Financials (TTM)

Gross Profit

$11.38M

Operating Income

$145.81M

EBITDA

$133.10M

Operating Cash Flow

$184.03M

Capital Expenditure

$41.00K

Free Cash Flow

$184.07M

Cash & ST Invst.

$256.02M

Total Debt

$36.23M

Alector Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$6.24M

-88.5%

Gross Profit

$3.98M

-48.9%

Gross Margin

63.78%

N/A

Market Cap

$220.73M

N/A

Market Cap/Employee

$1.26M

N/A

Employees

175

N/A

Net Income

$37.27M

-1696.9%

EBITDA

$29.31M

-466.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$219.79M

-40.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$26.81M

-20.6%

Short Term Debt

$9.42M

+7.6%

Return on Assets

-48.74%

N/A

Return on Invested Capital

-65.17%

N/A

Free Cash Flow

$41.69M

+24.5%

Operating Cash Flow

$41.69M

+24.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MOLNMolecular Partners AG
$4.05-5.73%
NKTXNkarta, Inc.
$2.06-3.74%
ABOSAcumen Pharmaceuticals, Inc.
$2.26-11.37%
FATEFate Therapeutics, Inc.
$1.17-4.88%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
ARTLArtelo Biosciences
$10.54+2.30%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.56-0.06%

Questions About ALEC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.